SCHEMBL30888949

SCHEMBL30888949

Cc1nc2ccc(Cl)nc2n1C(C)C

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DYRK1A Q13627 2/20 0.54
▸ CSNK1E P49674 1/20 0.54
▸ CLK1 P49759 1/20 0.54
▸ CLK2 P49760 1/20 0.54
▸ CLK3 P49761 1/20 0.54
▸ GSK3B P49841 1/20 0.54
▸ CDK5 Q00535 1/20 0.54
▸ CDK5R1 Q15078 1/20 0.54
▸ DYRK2 Q92630 1/20 0.54
▸ CLK4 Q9HAZ1 1/20 0.54
▸ DYRK4 Q9NR20 1/20 0.54
▸ DYRK1B Q9Y463 1/20 0.54
▸ CDK4 P11802 3/20 0.38
▸ CCND1 P24385 3/20 0.38
▸ CCND3 P30281 3/20 0.38
▸ CDK6 Q00534 3/20 0.38
▸ CYP11B2 P19099 3/20 0.35
▸ CYP11B1 P15538 2/20 0.35
▸ DAPK1 P53355 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21522732 1.00 DYRK1A (0.54) DYRK1ACSNK1ECLK1CLK2CLK3
SCHEMBL16084172 0.81 GSK3B (0.42) DYRK1ACSNK1ECLK1CLK2CLK3
SCHEMBL21539259 0.75 CDK4 (0.56) DYRK1ACSNK1ECLK1CLK2CLK3
SCHEMBL31113441 0.75 DYRK1A (0.43) DYRK1ACLK1DYRK2ALDH1A1MAPT
SCHEMBL25149020 0.75 DYRK1A (0.43) DYRK1ACLK1DYRK2ALDH1A1MAPT
SCHEMBL20740567 0.74 CDK5 (0.42) DYRK1ACSNK1ECLK1CLK2CLK3
SCHEMBL25149682 0.71 KDM4E (0.41) DYRK1ACSNK1ECLK1CLK2CLK3
SCHEMBL1106498 0.71 CSNK1E (0.47) DYRK1ACSNK1ECLK1CLK2CLK3
SCHEMBL20508523 0.70 DYRK1A (1.00) DYRK1ACSNK1ECLK1CLK2CLK3
SCHEMBL25149382 0.70 DYRK1A (0.58) DYRK1ACSNK1ECLK1CLK2CLK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4676931-A1 PYRROLO[2,1-F][1,2,4]TRIAZINES AND PREPARATION AND USES THEREOF BioSplice Therapeutics, Inc. (US) 2026-01-14 — — EP disclosed
WO-2024211797-A1 PYRROLO[2,1-F][1,2,4]TRIAZINES AND PREPARATION AND USES THEREOF BIOSPLICE THERAPEUTICS, INC. (US) 2024-10-10 — — WO disclosed
CN-118286225-A 2-Amino-pyridine or 2-amino-pyrimidine derivatives as cyclin dependent kinase inhibitors 辉瑞公司 2024-07-05 — — CN disclosed
CN-112313219-B 2-Amino-pyridine or 2-amino-pyrimidine derivatives as cyclin dependent kinase inhibitors 辉瑞公司 2024-04-26 — — CN disclosed
Send feedback